Industry Notes / Pharma / Chapter 2 of 20 · Bar
The profit pool is in the United States
The same molecule meets a much larger payer
China
7%
United States
17%
Health spending is about 7% of GDP in China and about 17% in the United States. A Chinese innovative drug often peaks in the tens of billions of yuan at home, and in the tens of billions of dollars in the US.
Source:WHO / 国家卫健委卫生总费用占 GDP 通行口径;引用前请核对最新年鉴
Research notes, not investment advice.